Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹416 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 11 Dec 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.39 | 1.82 |
Manager | Abhishek Bisen | Sailesh Raj Bhan |
ISIN Code | INF174KA1PW4 | INF204K01968 |
Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 1.82% | 3.25% |
6 Month | -3.52% | -1.91% |
1 Year | 14.85% | 15.97% |
3 Year | - | 20.02% |
5 Year | - | 22.55% |
SIP Return Analysis
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | -1.54% | 1.17% |
1 Year | 0.68% | 3.92% |
3 Year | - | 24.01% |
5 Year | - | 19.63% |
Rolling Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 31.01% | 18.19% |
3 Year | - | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.623% |
Sharp | - | 0.707% |
Beta | - | 0.908% |
Alpha | - | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Abhishek Bisen | Sailesh Raj Bhan |
Total AUM | ₹0 Cr | ₹96086 Cr |
Funds Managed | 33 | 5 |
Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 4.18 | 1.36 |
Small Cap | 31.72 | 27.14 |
Large Cap | 37.08 | 38.72 |
Mid Cap | 27.03 | 32.78 |
Sector Allocation
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.76 | 1.36 |
Basic Materials | 2.58 | - |
Healthcare | 95.66 | 98.64 |
Top Comparisons
ICICI Prudential Manufacturing Fund - Growth Option
3Y Returns21.98%
Tata Ethical Fund-Regular Plan - Growth Option
3Y Returns10.34%
HSBC Global Equity Climate Change Fund of Fund - Regular - Growth
3Y Returns3.49%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns8.37%
ITI Mid Cap Fund Regular - Growth
3Y Returns22.11%
DSP Midcap Fund - Regular Plan - Growth
3Y Returns15.72%
DSP Multi Asset Allocation Fund - Regular (G)
3Y Returns0%
Edelweiss Multi Asset Allocation Fund - Reg (G)
3Y Returns0%